Aug 31, 2017 20:05 pm UTC| Business
SAN DIEGO, Aug. 31, 2017 -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced the appointment...
TRACON Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference
Aug 31, 2017 20:05 pm UTC| Business
SAN DIEGO, Aug. 31, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Aeglea BioTherapeutics to Present at the 2017 Wells Fargo Healthcare Conference
Aug 31, 2017 20:05 pm UTC| Business
AUSTIN, Texas, Aug. 31, 2017 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases...
MKS Instruments Makes a Voluntary $75 Million Pre-Payment on its Term Loan
Aug 31, 2017 20:05 pm UTC| Business
ANDOVER, Mass., Aug. 31, 2017 -- MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today made a $75 million voluntary principal pre-payment...
Progenics Pharmaceuticals Provides Update on Timing of NDA Submission for AZEDRA®
Aug 31, 2017 20:05 pm UTC| Business
- All Sections of New Drug Application (NDA) Have Been Submitted to the FDA, Except Notification of Pre-Approval Inspection Readiness - -Manufacturer Has Requested Additional Time to Prepare for Pre-Approval Inspection...
Ambarella, Inc. Announces Second Quarter Fiscal Year 2018 Financial Results
Aug 31, 2017 20:05 pm UTC| Business
SANTA CLARA, Calif., Aug. 31, 2017 -- Ambarella, Inc. (NASDAQ:AMBA), a leading developer of low-power, HD and Ultra HD video compression and image processing semiconductors, today announced financial results for its...
Aduro Biotech to Present at Three Investor Conferences in the First Half of September
Aug 31, 2017 20:05 pm UTC| Business
BERKELEY, Calif., Aug. 31, 2017 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Aduro management will present at the following investor conferences in New York, NY the first half of September 2017: 2017...